Optimal recall period and response task for self-reported HIV medication adherence.
about
Self-report measures of medication adherence behavior: recommendations on optimal useImpact of HIV-related stigma on treatment adherence: systematic review and meta-synthesisDivergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) studyWork-related barriers and facilitators to antiretroviral therapy adherence in persons living with HIV infectionAdherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical SettingInvestigating partner abuse among HIV-positive men who have sex with menAppraising Viral Load Thresholds and Adherence Support Recommendations in the World Health Organization Guidelines for Detection and Management of Virologic Failure.Developing the Diagnostic Adherence to Medication Scale (the DAMS) for use in clinical practice.Computerized counseling reduces HIV-1 viral load and sexual transmission risk: findings from a randomized controlled trialEfficacy of an alcohol-focused intervention for improving adherence to antiretroviral therapy (ART) and HIV treatment outcomes - a randomised controlled trial protocol.Tenofovir-based preexposure prophylaxis for HIV infection among African women.Associations between the legal context of HIV, perceived social capital, and HIV antiretroviral adherence in North America.Discordance Between Drug Adherence as Reported by Patients and Drug Importance as Assessed by Physicians.Site nurse-initiated adherence and symptom support telephone calls for HIV-positive individuals starting antiretroviral therapy, ACTG 5031: substudy of ACTG 384.Medication adherence is a mediator of the relationship between ethnicity and event-free survival in patients with heart failure.An examination of the psychometric properties of the Antiretroviral General Adherence Scale (AGAS) in two samples of HIV-infected individuals.Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIVProvider-patient communication about adherence to anti-retroviral regimens differs by patient race and ethnicity.Correlates of antiretroviral adherence and viral load among transgender women living with HIVCorrelates of non-adherence to antiretroviral therapy in a cohort of HIV-positive drug users receiving antiretroviral therapy in Hanoi, Vietnam.Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.Body image disturbance and health behaviors among sexual minority men living with HIV.Evaluation of 3 approaches for assessing adherence to vaginal gel application in clinical trials.Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review.Antiretroviral concentrations in small hair samples as a feasible marker of adherence in rural KenyaCorrelation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis.Feasibility of motivational interviewing delivered by a glaucoma educator to improve medication adherenceRelationship between viral load and self-report measures of medication adherence among youth with perinatal HIV infection.Cognitive-behavioral therapy for the treatment of depression and adherence in patients with type 1 diabetes: pilot data and feasibility.Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settingsImproving coping skills for self-management of treatment side effects can reduce antiretroviral medication nonadherence among people living with HIV.Examining the link between patient satisfaction and adherence to HIV care: a structural equation modelAlcohol and associated characteristics among older persons living with human immunodeficiency virus on antiretroviral therapyMedication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South AfricaNeurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence.HIV treatment adherence measurement and reporting concordance in youth with perinatally acquired HIV infection and their caregiversDistress and type 2 diabetes-treatment adherence: A mediating role for perceived control.Moving toward a novel and comprehensive behavioral composite of engagement in HIV care.Predictors of Weight Change in Male HIV-Positive Injection Drug Users Initiating Antiretroviral Therapy in Hanoi, Vietnam.
P2860
Q26775742-A130D017-ECC9-4B88-87AC-434F6BB1F492Q26830838-0E60061D-4D66-4E62-83AA-7811198E8C4CQ27300707-3A2CB7B1-09BC-49C3-A172-10F6CDE283EFQ28389395-FA574BEB-66C0-4177-8348-49F8666E43EBQ28552015-49F7C71A-07AC-4D27-A6FD-3728C7DFCA1FQ28658841-D90E5951-AAA1-41B7-B6A3-61EB7251F98DQ30492033-173F1B0D-EC24-4168-BF42-1B0F09FE5211Q30528671-69692552-A2AF-4B58-B0A0-C0BA83BD415CQ30576961-8DEFCD0C-EFF4-440A-AE1D-83A821DF0269Q30587688-6F941F46-1DBE-4F57-B09C-F8D9486C340EQ30621914-638861E7-532A-4CEB-8E32-75B6D8DDAA60Q31125998-1DBAC31B-4CB5-4217-92A5-1F292C218409Q33572182-036D0DD2-5F80-4FFC-B8EB-6EFB284BD613Q33602445-F23C1955-28B3-4F21-98A0-8DE34F8F8CFCQ33645086-446D513F-792B-4AAD-A749-4777E41C45D7Q33679085-1B16EBE3-B66C-423D-AD47-870829B3FA4EQ33703513-F5F3DC9A-415F-432F-8CBA-AD3E0F5B042FQ33717560-41F4EE89-3FA1-4C28-8999-8BB812B37ACAQ33745457-56266F17-0F1E-4033-9793-9D28E2E46006Q33774290-B3C6D851-8E29-4D48-B861-4147D3F0B467Q33885987-5CB3C38A-89F7-49C3-B460-F9FD3C170F85Q33889271-C7CDEB83-BEEF-406D-9D78-32C0B373EDDFQ34034381-F5E222A6-CC42-41BD-8A08-1514A63C449EQ34066197-E98CF5ED-7A3A-490D-9A24-4676B42DE279Q34098406-B8C40847-DF7B-4958-BE8E-9701BB88DC2AQ34149863-75920A70-5CC0-414D-8DB5-809D5C23BC10Q34188261-537E8E5F-673F-4456-B3B5-FBE5DA95B54FQ34307909-BC94AFA7-3F14-480B-8D0E-F6B47CEA63BCQ34401613-16505133-260B-4F76-8E47-B304E16CFF5FQ34447758-5F2AAC46-F6A8-4C34-B27A-933BB1A41BE2Q34538784-1856076E-3CDC-450D-86D0-A75293063241Q34575619-A65CB596-C56E-4F75-8BE7-A50F3B75AAB0Q34598377-BC11473B-F952-4A2B-BE7B-B8BD3D5A8424Q34606560-C63B105C-CA86-4C11-AE81-4C73C6C0E217Q34624904-D0F23182-C75B-499D-836C-4DEA328FFCC3Q34629825-2277379C-B0D3-4C6B-8347-2BD1BC3E9F2BQ34802665-C29E3003-B03E-4123-BD4E-E3DAD4D0629DQ35072563-0E872BBD-FBF4-404B-883B-5D50BED5E37AQ35108079-338EFBF5-70AD-4753-AA0F-945563CC2516Q35110006-91FA9B0F-71D0-44BF-B7F4-DC5986B3AB87
P2860
Optimal recall period and response task for self-reported HIV medication adherence.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Optimal recall period and response task for self-reported HIV medication adherence.
@en
Optimal recall period and response task for self-reported HIV medication adherence.
@nl
type
label
Optimal recall period and response task for self-reported HIV medication adherence.
@en
Optimal recall period and response task for self-reported HIV medication adherence.
@nl
prefLabel
Optimal recall period and response task for self-reported HIV medication adherence.
@en
Optimal recall period and response task for self-reported HIV medication adherence.
@nl
P2093
P1433
P1476
Optimal recall period and response task for self-reported HIV medication adherence.
@en
P2093
Helene Hardy
Paul R Skolnik
Steven A Safren
William Coady
William H Rogers
P2888
P356
10.1007/S10461-007-9261-4
P577
2007-06-19T00:00:00Z